Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Puma Biotech: Q4 Earnings Snapshot
Puma Biotech: Q4 Earnings Snapshot
Associated Press Finance
Fri, February 27, 2026 at 7:15 AM GMT+9 1 min read
In this article:
PBYI
-1.04%
LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported earnings of $13.4 million in its fourth quarter.
The Los Angeles-based company said it had net income of 26 cents per share. Earnings, adjusted for stock option expense, were 29 cents per share.
The biopharmaceutical company posted revenue of $75.5 million in the period.
For the year, the company reported profit of $31.1 million, or 61 cents per share. Revenue was reported as $228.4 million.
For the current quarter ending in March, Puma Biotech said it expects revenue in the range of $38 million to $42 million.
The company expects full-year revenue in the range of $214 million to $221 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on PBYI at
Terms and Privacy Policy
Privacy Dashboard
More Info